Research Group

HyperMIND

Group leader: Mathilde Hauge Lerche

In the HyperMIND group, we explore how the brain functions as a metabolic organ and study how it
interacts with the rest of the body through metabolism. To do this, we make molecular activity visible
using hyperpolarized magnetic resonance (MR) – a technique that greatly enhances the sensitivity of MR
active nuclei. We develop hyperpolarized metabolic contrast agents via dissolution dynamic nuclear
polarization (dDNP) and apply MRI, MRS, NMR, and metabolomics in our studies. Our interdisciplinary
team bridges physics, chemistry, and biochemistry working across species and scales to uncover
metabolic dysfunctions and translate findings from fundamental research to potential strategies for
prevention, diagnosis, and treatment.

Our group, summer 2025

Research focus

Novel Metabolic Contrast Agents

We develop and investigate novel metabolic contrast agents for hyperpolarized MRI, with a particular focus on 13C-, 15N-, and 2H-labeled compounds. Our work spans from the conceptual design and chemical synthesis of probe molecules to the optimization of hyperpolarization protocols using dissolution dynamic nuclear polarization (dDNP). In parallel, we develop acquisition strategies tailored to the specific physical, chemical, and biochemical properties of each agent to enhance signal utility and maximize biological insight. We apply these probes in preclinical models to explore their in vivo behavior, focusing on their metabolic activity, biodistribution, and potential for non-invasive imaging of disease-related processes.

People:

Ingeborg Sæten Skre

Ingeborg Sæten Skre PhD student Department of Health Technology

Per Magnus Albin Karlsson

Per Magnus Albin Karlsson Senior Researcher Department of Health Technology

Translation of hyperpolarized MRI from animals to humans

Our goal is to advance hyperpolarized MRI into a viable tool for both research and clinical practice. Bridging the gap from preclinical studies in rodents and pigs to human applications, we refine, enhance, and develop hardware, software, and methodology to maximize clinical impact. To fully realize the potential of hyperpolarized MRI for noninvasive metabolic imaging, we work to harmonize techniques across sites, enabling multisite trials and ensuring robust, reproducible clinical implementation.

People:

Rie Beck Olin

Rie Beck Olin Assistant Professor Department of Health Technology

Kristina Pilgaard Jacobsen

Kristina Pilgaard Jacobsen PhD student Department of Health Technology

Metabolic imaging of the brain with hyperpolarized MRI

We develop hyperpolarized MRI methods to investigate brain metabolism and its dynamic relationship with brain activity. By enabling real-time metabolic imaging, we seek to connect biochemical processes with functional responses, offering new insights into neurological function. Our research explores how metabolic changes in the brain interact with whole-body physiology and disease, providing a foundation for future studies on brain function and therapeutic development. Through advancements in imaging sequences and reconstruction methods, we want to push the limits of what hyperpolarized MRI can reveal about the brain in both health and disease.

People:

Rie Beck Olin

Rie Beck Olin Assistant Professor Department of Health Technology

Ingeborg Sæten Skre

Ingeborg Sæten Skre PhD student Department of Health Technology

Kristina Pilgaard Jacobsen

Kristina Pilgaard Jacobsen PhD student Department of Health Technology

Hyperpolarization of water and metabolites using UV-generated radicals

We study how nuclear spins can be efficiently hyperpolarized using non-persistent radicals generated by UV irradiation of precursors like pyruvic acid. These radicals decompose upon dissolution, yielding radical-free hyperpolarized water or metabolite solutions. This extends relaxation times, enabling prolonged NMR detection and the potential for sample reuse in multiple hyperpolarized experiments. We apply these radical-free solutions to investigate metabolic markers in healthy and diseased tissue extracts and to study protein hydration dynamics. 

People:

Fabian Hecker

Fabian Hecker Postdoc Department of Health Technology

Per Magnus Albin Karlsson

Per Magnus Albin Karlsson Senior Researcher Department of Health Technology

Group Leader

Mathilde Hauge Lerche

Mathilde Hauge Lerche Group leader, Associate Professor Department of Health Technology Phone: +45 45253686

Mathilde Hauge Lerche is an associate professor at DTU's Department of Health Technology, leading research in hyperpolarized MR, metabolism, and translational imaging. Her work focuses on developing biomarkers and methods for in vivo studies. With a PhD in Molecular Biology, she’s worked across academia and industry, including biotech leadership and GE Healthcare. At DTU, she leads the Translational Imaging Center, supervises PhD students, and teaches medical imaging. Her research, funded by major bodies, has over 50 papers and 9,000+ citations.